'Meaningful use' for EHRs coming next year

Share this article:
Electronic health records (EHRs) are poised to get a boost from the federal government's “meaningful use” incentive program next year, begging the question: can these tools increase engagement between physician and patient?
Research firm Verilogue and Ortho-McNeil-Janssen Pharmaceuticals explored EHRs' potential to improve in-office dialogue. During a session at the Pharmaceutical Marketing Research Group (PMRG) Institute fall meeting, Verilogue showed attendees videos comparing physician-patient interaction with and without EHRs.
“The quality of the interaction between the physician and patient appeared to be enhanced when the doctor had the patient's medical records immediately at hand via computer,” said co-presenter Juliana Mastroserio, senior market research manager, internal medicine, Ortho-McNeil-Janssen. “The physician was able to pull up information quickly and engaged the patient by sharing information related to her current condition.”
Verilogue president Jeff Kozloff compared it to the difference between a rep detailing a doctor with a printed visual aid vs. a tablet PC. Doctors need training in how to make best use of the computer to support, not supplant, communication. “This is a great opportunity for [industry] to close the gap in the physician-patient dynamic,” Kozloff said. “Without the right training and industry content, the gap could widen.”
Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Features

Email Newsletters

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Features

Read the complete September 2014 Digital Edition

Read the complete September 2014 Digital Edition

Click the above link to access the complete Digital Edition of the August 2014 issue of MM&M, with all text, charts and pictures.

Medical marketing needs mainstream Mad Men

Medical marketing needs mainstream Mad Men

Agencies must generate emotional resonance with the target audience, not unlike Apple, Pepsi or Nike

Are discounts cutting out co-pays?

GSK's decision to cut Advair's price spurred some PBMs to put it back on formulary. Will drugmaker discounts diminish the need for loyalty programs? How can these programs stay relevant beyond giving co-pay assistance?